Home›Stock Screener›Krishna Institute of Medical Sciences›Financial Statements

Krishna Institute of Medical Sciences Complete Financial Statements

12 Years of Data
2026 - 2015

In FY2026, Krishna Institute of Medical Sciences (KIMS) reported revenue ₹1,087 Cr, net profit ₹33 Cr and EPS ₹1.06, with a net profit margin of 3.0% and ROE of 1.5%. Full financial statements from FY2015 to FY2026 (12 years) — income statement, balance sheet and cash flow in ₹ Crores. Download as Excel or CSV. Review KIMS earnings multiple to evaluate earnings-based valuation against sector peers.

Complete Financial Data Export

Profitability Ratios

Net Profit Margin 3.04% 2026 data
EBITDA Margin 19.14% 2026 data
Operating Margin 18.00% 2026 data
Return on Assets 0.43% 2026 data
Return on Equity 1.47% 2026 data

Balance Sheet Ratios

Current Ratio 0.24 2026 data
Equity Ratio 28.96% 2026 data
Asset Turnover 0.14 2026 data

KIMS Revenue, Net Profit & EBITDA — Year-on-Year Growth

KIMS YoY (Mar 2025 vs Mar 2026) — revenue +33.9%, net profit -68.9%, EBITDA -2.3%, expenses +46.7%. Explore KIMS intrinsic value to estimate fundamental worth using multiple valuation models.

Revenue Growth
+33.9%
Year-over-Year
Net Profit Growth
-68.9%
Year-over-Year
EBITDA Growth
-2.3%
Year-over-Year
Expense Growth
+46.7%
Year-over-Year
Assets Growth
+35.3%
Year-over-Year
Equity Growth
-7.1%
Year-over-Year
Operating Cash Flow Growth
+11.7%
Year-over-Year
Investing Cash Flow Growth
-48.2%
Year-over-Year
Financing Cash Flow Growth
+150.2%
Year-over-Year

KIMS Income Statement — Revenue, EBITDA & Net Profit

Krishna Institute of Medical Sciences revenue ₹1,087 Cr, EBITDA ₹208 Cr, net profit ₹33 Cr, EPS ₹1.06 (2026) — net profit margin 3.0%. For live price, earnings ratios and company overview, see KIMS share price.

Periods ₹ Crores
Particulars Mar 2026 Sept 2025 Mar 2025 Jun 2025 Dec 2025 Sept 2024 Mar 2024 Jun 2024 Dec 2024 Sept 2023 Mar 2023 Jun 2023 Dec 2023 Sept 2022 Mar 2022 Jun 2022 Dec 2022 Sept 2021 Mar 2021 Jun 2021 Dec 2021 Sept 2020 Mar 2020 Jun 2020 Dec 2020
Revenue 1,087 965 812 879 1,003 782 638 693 790 655 581 609 609 588 388 501 569 417 363 478 398 411 268 206 361
Expenses 879 757 599 679 799 559 475 509 585 475 413 449 459 412 259 358 411 283 258 330 264 268 203 165 268
EBITDA 208 208 213 200 204 223 163 184 205 180 168 160 150 177 129 143 158 134 105 148 134 143 65 40 93
Operating Profit Margin % 18.00% 21.00% 25.00% 22.00% 20.00% 28.00% 25.00% 26.00% 24.00% 27.00% 28.00% 26.00% 24.00% 27.00% 31.00% 28.00% 27.00% 31.00% 28.00% 30.00% 33.00% 34.00% 24.00% 18.00% 26.00%
Depreciation 85 66 53 53 79 41 46 39 45 33 35 32 35 31 19 29 33 18 17 17 19 16 17 17 20
Interest 68 45 27 33 57 20 16 18 26 9 5 9 12 8 4 6 12 3 7 6 3 7 10 9 9
Profit Before Tax 55 97 134 114 69 162 100 127 135 139 127 119 102 138 107 107 113 113 81 125 112 120 38 14 65
Tax 22 25 28 29 17 42 29 32 42 37 29 32 26 31 24 28 31 29 22 33 28 29 10 5 17
Net Profit 33 72 106 85 52 121 72 95 93 101 99 87 77 106 83 79 82 84 59 92 84 90 28 9 48
Earnings Per Share (₹) 1.06 1.67 2.54 1.96 1.33 2.68 8.18 10.82 2.22 11.50 11.65 10.10 8.98 12.14 10.08 8.74 9.49 10.34 7.72 11.48 10.14 11.21 3.72 1.49 6.55

KIMS Balance Sheet — Assets, Liabilities & Shareholders' Equity

KIMS total assets ₹7,759 Cr, total equity ₹2,247 Cr, total liabilities ₹ Cr (2026) — ROE 1.5%.

Years Annual Data ₹ Crores
Particulars 2026 2025 2024 2023 2022 2021 2020 2019 2018
ASSETS
Total Assets 7,759 5,736 3,852 2,941 1,907 1,436 1,196 1,118 958
Current Assets 937 697 547 478 393 451 220 174 156
Fixed Assets 5,978 3,349 2,434 1,766 1,005 931 916 863 755
Capital Work in Progress 606 1,214 600 477 21 9 2 0 0
Investments 97 99 157 68 333 0 0 0 0
Other Assets 0 1,075 660 630 549 496 278 254 203
LIABILITIES
Total Liabilities
Current Liabilities 3,961 2,481 1,307 707 282 282 366 351 347
Non-Current Liabilities
SHAREHOLDERS' EQUITY
Total Equity 2,247 2,419 2,093 1,938 1,411 876 611 566 -138
Share Capital 80 80 80 80 80 78 75 75 50
Reserves & Surplus 2,167 2,058 1,748 1,590 1,307 786 523 466 -209

KIMS Cash Flow Statement — Operating, Investing & Financing

Krishna Institute of Medical Sciences operating cash flow ₹582 Cr, investing ₹-1,116 Cr, financing ₹543 Cr, net cash flow ₹9 Cr (2025).

Periods ₹ Crores
Particulars March 2025 March 2024 March 2023 March 2022 March 2021 March 2020 March 2019 March 2018 March 2017 March 2016 March 2015
Operating Activities 582 521 432 324 356 202 134 106 82 95 64
Investing Activities -1,116 -753 -416 -412 -354 -125 -110 -64 -100 -41 -71
Financing Activities 543 217 20 61 10 -44 -27 -39 24 -66 12
Net Cash Flow 9 -15 36 -27 12 33 -3 3 5 -11 5